Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...

The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.

What is contentment, and is it even possible with the daily struggles of ALS? Columnist Kristin Neva offers her observations as a caregiver.

ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...

The Mayo Clinic was awarded $12 million to support a study that will give ALS patients access to the investigational therapy ...

Clene will have an in-person meeting with the FDA before the end of November to discuss a potential CNM-Au8 accelerated ...

Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...

A $500,000 MDA research grant to a Mass General investigator will support the HEALEY ALS platform trial that's testing ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

Living well with ALS means we must be mindful, writes columnist Dagmar Munn, who shares an anecdote about an unplanned long walk.